Karen Overbye

767 total citations
10 papers, 507 citations indexed

About

Karen Overbye is a scholar working on Molecular Biology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Karen Overbye has authored 10 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Molecular Medicine and 2 papers in Infectious Diseases. Recurrent topics in Karen Overbye's work include Cancer therapeutics and mechanisms (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Microbial Natural Products and Biosynthesis (2 papers). Karen Overbye is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Microbial Natural Products and Biosynthesis (2 papers). Karen Overbye collaborates with scholars based in United States. Karen Overbye's co-authors include J. Barrett, Paul Margolin, Charles F. Albright, Janice Pero, Phillips W. Robbins, Hong Ma, Sam Kunes, Mark A. Fox, David Botstein and Charles Gill and has published in prestigious journals such as Genetics, Journal of Bacteriology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Karen Overbye

10 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karen Overbye United States	8	345	82	77	76	75	10	507
Feng Song China	16	541 1.6×	84 1.0×	58 0.8×	124 1.6×	56 0.7×	35	792
Olga V. Efremenkova Russia	14	290 0.8×	193 2.4×	49 0.6×	108 1.4×	88 1.2×	65	678
Francesco Parenti Italy	15	330 1.0×	160 2.0×	45 0.6×	55 0.7×	78 1.0×	21	594
Emiliana Corti Italy	9	275 0.8×	159 1.9×	54 0.7×	46 0.6×	34 0.5×	12	416
S Roychoudhury United States	10	389 1.1×	58 0.7×	36 0.5×	35 0.5×	49 0.7×	12	600
J. Janeček Czechia	11	312 0.9×	69 0.8×	29 0.4×	37 0.5×	41 0.5×	43	473
Deborah Walker United States	9	467 1.4×	89 1.1×	70 0.9×	227 3.0×	39 0.5×	12	650
Dominique Le Beller France	7	414 1.2×	106 1.3×	46 0.6×	147 1.9×	21 0.3×	7	517
David Sychantha Canada	14	323 0.9×	130 1.6×	63 0.8×	88 1.2×	51 0.7×	23	628
Priti Saxena India	9	372 1.1×	230 2.8×	48 0.6×	66 0.9×	106 1.4×	14	610

Countries citing papers authored by Karen Overbye

Since Specialization

Citations

This map shows the geographic impact of Karen Overbye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Overbye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Overbye more than expected).

Fields of papers citing papers by Karen Overbye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Overbye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Overbye. The network helps show where Karen Overbye may publish in the future.

Co-authorship network of co-authors of Karen Overbye

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Overbye. A scholar is included among the top collaborators of Karen Overbye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Overbye. Karen Overbye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Singh, Sheo B., James Occi, Hiranthi Jayasuriya, et al.. (2007). Antibacterial Evaluations of Thiazomycin. The Journal of Antibiotics. 60(9). 565–571. 37 indexed citations

Overbye, Karen, et al.. (2007). AM-7359 – a Novel Oxazolidinone with Low Resistance Potential and Potent Activity Against Drug Resistant Pathogens. Journal of Chemotherapy. 19(3). 249–255. 3 indexed citations

Overbye, Karen & J. Barrett. (2005). Antibiotics: Where did we go wrong?. Drug Discovery Today. 10(1). 45–52. 172 indexed citations

Kuklin, Nelly A., Timothy W. Tobery, Leslie D. Cope, et al.. (2003). Real-Time Monitoring of Bacterial Infection In Vivo: Development of Bioluminescent Staphylococcal Foreign-Body and Deep-Thigh-Wound Mouse Infection Models. Antimicrobial Agents and Chemotherapy. 47(9). 2740–2748. 61 indexed citations

Toney, Jeffrey H., et al.. (1997). High-Yield Expression, Purification, and Characterization of Active, SolubleBacteroides fragilisMetallo-β-Lactamase, CcrA. Protein Expression and Purification. 9(3). 355–362. 16 indexed citations

Robbins, Phillips W., et al.. (1992). Cloning and high-level expression of chitinase-encoding gene of Streptomyces plicatus. Gene. 111(1). 69–76. 104 indexed citations

Hammond, Gail G., Patrick J. Cassidy, & Karen Overbye. (1991). Novobiocin-dependent topA deletion mutants of Escherichia coli. Journal of Bacteriology. 173(17). 5564–5567. 5 indexed citations

Kunes, Sam, Hong Ma, Karen Overbye, Mark A. Fox, & David Botstein. (1987). Fine Structure Recombinational Analysis of Cloned Genes Using Yeast Transformation. Genetics. 115(1). 73–81. 43 indexed citations

Overbye, Karen, Srinjan Basu, & Paul Margolin. (1983). Loss of DNA Topoisomerase I Activity Alters Many Cellular Functions in Salmonella typhimurium. Cold Spring Harbor Symposia on Quantitative Biology. 47(0). 785–791. 21 indexed citations

10.

Overbye, Karen & Paul Margolin. (1981). Role of the supX gene in ultraviolet light-induced mutagenesis in Salmonella typhimurium. Journal of Bacteriology. 146(1). 170–178. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact